Search

everythinglearnresearchcommunity

for

Search:↓

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

Stress and emotional factors can worsen skin conditions by affecting the immune system.

Pregnancy can cause specific skin conditions that need correct diagnosis and treatment to protect both mother and baby.

Dupilumab may cause significant hair loss, which can reverse after stopping the drug.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

High potency topical steroids are the most effective treatment for pediatric alopecia areata.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Stress increases a factor in mice that leads to hair loss, and blocking this factor may prevent it.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

Freezing gamma-irradiated amniotic fluid may help hair growth and speed up the growth phase.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Mogamulizumab can cause hair loss and skin rashes.

COVID-19 vaccination may trigger lupus in some people.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

High levels of the protein Flightless I worsen ulcerative colitis symptoms in mice.